Inhibitors of cysteine proteases and methods of use thereof
申请人:Pardes Biosciences, Inc.
公开号:US11524940B1
公开(公告)日:2022-12-13
The disclosure provides compounds with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease.
[EN] INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DE PROTÉASES À CYSTÉINE ET LEURS PROCÉDÉS D'UTILISATION
申请人:PARDES BIOSCIENCES INC
公开号:WO2021212039A1
公开(公告)日:2021-10-21
The disclosure provides compounds with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease.
[EN] INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DE CYSTÉINE PROTÉASES ET LEURS PROCÉDÉS D'UTILISATION
申请人:PARDES BIOSCIENCES INC
公开号:WO2021252644A1
公开(公告)日:2021-12-16
The disclosure provides compounds of formula II with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease. Formula II
Studies on the nitrosation ofN-silylated cyclopentenylamines
作者:Roberto Mart�nez Alvarez、Angel S�nchez V�zquez、Michael Hananck、L. R. Subramanian